Completed
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
NCT00053248
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- UCLA Department of Medicine, Division of Hematology/Oncology Los Angeles, California, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States